[1] |
Weidinger S, Beck LA, Bieber T, et al. Atopic dermatitis[J]. Nat Rev Dis Primers, 2018,4(1):1. doi: 10.1038/s41572⁃018⁃0001⁃z.
|
[2] |
Paller AS, Kong HH, Seed P, et al. The microbiome in patients with atopic dermatitis[J]. J Allergy Clin Immunol, 2019,143(1):26⁃35. doi: 10.1016/j.jaci.2018.11.015.
|
[3] |
Handelsman J, Rondon MR, Brady SF, et al. Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products[J]. Chem Biol, 1998,5(10):R245⁃249.
|
[4] |
Chen K, Pachter L. Bioinformatics for whole⁃genome shotgun sequencing of microbial communities[J]. PLoS Comput Biol, 2005,1(2):106⁃112. doi: 10.1371/journal.pcbi.0010024.
|
[5] |
Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain⁃terminating inhibitors[J]. Proc Natl Acad Sci U S A, 1977,74(12):5463⁃5467. doi: 10.1073/pnas.74.12.5463.
|
[6] |
Schadt EE, Turner S, Kasarskis A. A window into third⁃generation sequencing[J]. Hum Mol Genet, 2010,19(R2):R227⁃240. doi: 10.1093/hmg/ddq416.
|
[7] |
NIH HMP Working Group, Peterson J, Garges S, et al. The NIH human microbiome project[J]. Genome Res, 2009,19(12):2317⁃2323. doi: 10.1101/gr.096651.109.
|
[8] |
Martin TC, Visconti A, Spector TD, et al. Conducting metagenomic studies in microbiology and clinical research[J]. Appl Microbiol Biotechnol, 2018,102(20):8629⁃8646. doi: 10.1007/s00253⁃018⁃9209⁃9.
|
[9] |
Pascal M, Perez⁃Gordo M, Caballero T, et al. Microbiome and allergic diseases[J]. Front Immunol, 2018,9:1584. doi: 10.3389/fimmu.2018.01584.
|
[10] |
Kim BE, Leung D. Significance of skin barrier dysfunction in atopic dermatitis[J]. Allergy Asthma Immunol Res, 2018,10(3):207⁃215. doi: 10.4168/aair.2018.10.3.207.
|
[11] |
Bending D, Ono M. Interplay between the skin barrier and immune cells in patients with atopic dermatitis unraveled by means of mathematical modeling[J]. J Allergy Clin Immunol, 2017,139(6):1790⁃1792. doi: 10.1016/j.jaci.2017.03.015.
|
[12] |
Clausen ML, Edslev SM, Andersen PS, et al. Staphylococcus aureus colonization in atopic eczema and its association with filaggrin gene mutations[J]. Br J Dermatol, 2017,177(5):1394⁃1400. doi: 10.1111/bjd.15470.
|
[13] |
Williams MR, Nakatsuji T, Sanford JA, et al. Staphylococcus aureus induces increased serine protease activity in keratinocytes[J]. J Invest Dermatol, 2017,137(2):377⁃384. doi: 10.1016/j.jid. 2016.10.008.
|
[14] |
Czarnowicki T, Krueger JG, Guttman⁃Yassky E. Novel concepts of prevention and treatment of atopic dermatitis through barrier and immune manipulations with implications for the atopic march[J]. J Allergy Clin Immunol, 2017,139(6):1723⁃1734. doi: 10.1016/j.jaci.2017.04.004.
|
[15] |
Chen YE, Tsao H. The skin microbiome: current perspectives and future challenges[J]. J Am Acad Dermatol, 2013,69(1):143⁃155. doi: 10.1016/j.jaad.2013.01.016.
|
[16] |
Oh J, Byrd AL, Deming C, et al. Biogeography and individuality shape function in the human skin metagenome[J]. Nature, 2014,514(7520):59⁃64. doi: 10.1038/nature13786.
|
[17] |
Nakatsuji T, Chen TH, Narala S, et al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis[J]. Sci Transl Med, 2017,9(378). pii: eaah4680. doi: 10.1126/scitranslmed.aah4680.
|
[18] |
Geoghegan JA, Irvine AD, Foster TJ. Staphylococcus aureus and atopic dermatitis: a complex and evolving relationship[J]. Trends Microbiol, 2018,26(6):484⁃497. doi: 10.1016/j.tim.2017. 11.008.
|
[19] |
Totté JE, van der Feltz WT, Hennekam M, et al. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta⁃analysis[J]. Br J Dermatol, 2016,175(4):687⁃695. doi: 10.1111/bjd.14566.
|
[20] |
Kong HH, Oh J, Deming C, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis[J]. Genome Res, 2012,22(5):850⁃859. doi: 10.1101/gr.131029.111.
|
[21] |
Lee SY, Lee E, Park YM, et al. Microbiome in the gut⁃skin axis in atopic dermatitis[J]. Allergy Asthma Immunol Res, 2018,10(4):354⁃362. doi: 10.4168/aair.2018.10.4.354.
|
[22] |
Abrahamsson TR, Jakobsson HE, Andersson AF, et al. Low diversity of the gut microbiota in infants with atopic eczema[J]. J Allergy Clin Immunol, 2012,129(2):434⁃440, 440.e1⁃2. doi: 10.1016/j.jaci.2011.10.025.
|
[23] |
Kim JE, Kim HS. Microbiome of the skin and gut in atopic dermatitis (ad): understanding the pathophysiology and finding novel management strategies[J]. J Clin Med, 2019,8(4). pii: E444. doi: 10.3390/jcm8040444.
|
[24] |
Nowrouzian FL, Lina G, Hodille E, et al. Superantigens and adhesins of infant gut commensal Staphylococcus aureus strains and association with subsequent development of atopic eczema[J]. Br J Dermatol, 2017,176(2):439⁃445. doi: 10.1111/bjd. 15138.
|
[25] |
Dou J, Zeng J, Wu K, et al. Microbiosis in pathogenesis and intervention of atopic dermatitis[J]. Int Immunopharmacol, 2019,69:263⁃269. doi: 10.1016/j.intimp.2019.01.030.
|
[26] |
Nakatsuji T, Chiang HI, Jiang SB, et al. The microbiome extends to subepidermal compartments of normal skin[J]. Nat Commun, 2013,4:1431. doi: 10.1038/ncomms2441.
|
[27] |
Nakatsuji T, Chen TH, Two AM, et al. Staphylococcus aureus exploits epidermal barrier defects in atopic dermatitis to trigger cytokine expression[J]. J Invest Dermatol, 2016,136(11):2192⁃2200. doi: 10.1016/j.jid.2016.05.127.
|
[28] |
Mohajeri MH, Brummer R, Rastall RA, et al. The role of the microbiome for human health: from basic science to clinical applications[J]. Eur J Nutr, 2018,57(Suppl 1):1⁃14. doi: 10. 1007/s00394⁃018⁃1703⁃4.
|
[29] |
Kim HW, Hong R, Choi EY, et al. A probiotic mixture regulates T cell balance and reduces atopic dermatitis symptoms in mice[J]. Front Microbiol, 2018,9:2414. doi: 10.3389/fmicb.2018.02 414.
|
[30] |
Huang R, Ning H, Shen M, et al. Probiotics for the treatment of atopic dermatitis in children: a systematic review and meta⁃analysis of randomized controlled trials[J]. Front Cell Infect Microbiol, 2017,7:392. doi: 10.3389/fcimb.2017.00392.
|
[31] |
Kim SO, Ah YM, Yu YM, et al. Effects of probiotics for the treatment of atopic dermatitis: a meta⁃analysis of randomized controlled trials[J]. Ann Allergy Asthma Immunol, 2014,113(2):217⁃226. doi: 10.1016/j.anai.2014.05.021.
|
[32] |
Cabana MD, McKean M, Caughey AB, et al. Early probiotic supplementation for eczema and asthma prevention: a randomized controlled trial[J]. Pediatrics, 2017,140(3). pii: e20163000. doi: 10.1542/peds.2016⁃3000.
|
[33] |
Rather IA, Bajpai VK, Kumar S, et al. Probiotics and atopic dermatitis: an overview[J]. Front Microbiol, 2016,7:507. doi: 10.3389/fmicb.2016.00507.
|
[34] |
Meisel JS, Sfyroera G, Bartow⁃McKenney C, et al. Commensal microbiota modulate gene expression in the skin[J]. Microbiome, 2018,6(1):20. doi: 10.1186/s40168⁃018⁃0404⁃9.
|